HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angelo Sidoni Selected Research

Phospholipase A2 Receptors

1/2021PLA2R Immunohistochemistry Staining in Membranous Glomerulopathy: A Challenging Stain to Interpret But a Potentially Useful Diagnostic Tool.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Angelo Sidoni Research Topics

Disease

41Neoplasms (Cancer)
12/2023 - 01/2003
22Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2021 - 01/2003
16Breast Neoplasms (Breast Cancer)
12/2023 - 01/2005
10Lung Neoplasms (Lung Cancer)
10/2021 - 01/2015
5Inflammation (Inflammations)
01/2021 - 01/2015
4Sarcoma (Soft Tissue Sarcoma)
01/2022 - 08/2014
4Adenocarcinoma of Lung
01/2018 - 11/2015
3Celiac Disease (Celiac Sprue)
02/2022 - 06/2017
3Papillary Thyroid Cancer
09/2021 - 01/2019
3Anaplastic Thyroid Carcinoma
09/2021 - 01/2019
3Thyroid Neoplasms (Thyroid Cancer)
09/2021 - 01/2019
3Carcinoma (Carcinomatosis)
01/2020 - 09/2008
3Carcinogenesis
03/2018 - 11/2013
3Margins of Excision
12/2015 - 11/2006
2Prostatic Neoplasms (Prostate Cancer)
06/2021 - 01/2017
2Renal Cell Carcinoma (Grawitz Tumor)
04/2020 - 07/2012
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 11/2006
2Nephrotic Syndrome (Syndrome, Nephrotic)
01/2017 - 01/2017
2Renal Insufficiency (Renal Failure)
01/2017 - 01/2015
2Primary Myelofibrosis (Myelosclerosis)
01/2017 - 01/2017
2Embryonal Rhabdomyosarcoma
09/2015 - 04/2014
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2015 - 01/2010
2Lymphoma (Lymphomas)
11/2009 - 02/2009
2Granular Cell Tumor
01/2008 - 01/2007
2Rectal Neoplasms (Rectal Cancer)
11/2006 - 11/2005
1Triple Negative Breast Neoplasms
12/2023
1Melanoma (Melanoma, Malignant)
05/2023
1Hypercholesterolemia
03/2023
1Congenital Abnormalities (Deformity)
01/2023
1Nasal Obstruction
01/2023
1Sensorineural Hearing Loss
01/2023
1Eosinophilia
01/2023
1Vasculitis (Vasculitides)
01/2023
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2023
1Bone Neoplasms (Bone Cancer)
06/2021

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
05/2023 - 12/2003
10ErbB Receptors (EGF Receptor)IBA
12/2020 - 05/2005
8Immune Checkpoint InhibitorsIBA
05/2023 - 12/2020
7Biomarkers (Surrogate Marker)IBA
04/2021 - 05/2008
5Phenobarbital (Luminal)FDA Link
12/2023 - 12/2016
5EnzymesIBA
06/2021 - 11/2006
5Anaplastic Lymphoma KinaseIBA
12/2020 - 09/2006
5Tyrosine Kinase InhibitorsIBA
04/2020 - 01/2015
4Messenger RNA (mRNA)IBA
01/2021 - 12/2016
3LigandsIBA
02/2022 - 01/2020
3Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2021 - 02/2019
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
09/2020 - 01/2013
3Interleukin-6 (Interleukin 6)IBA
01/2020 - 01/2013
3Trastuzumab (Herceptin)FDA Link
01/2012 - 05/2006
2LipidsIBA
03/2023 - 01/2013
2CholesterolIBA
03/2023 - 01/2015
2AntibodiesIBA
01/2023 - 06/2017
2Cadherins (E-Cadherin)IBA
09/2021 - 01/2016
2prolinedithiocarbamate (PDTC)IBA
09/2021 - 01/2019
2Pyruvaldehyde (Methylglyoxal)IBA
06/2021 - 01/2019
2KynurenineIBA
04/2021 - 01/2021
2Tryptophan (L-Tryptophan)FDA Link
04/2021 - 01/2021
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2020 - 01/2020
2Vitamin EFDA LinkGeneric
01/2020 - 01/2017
2ParaffinIBA
12/2018 - 01/2014
2CrizotinibIBA
04/2018 - 04/2018
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
03/2018 - 01/2016
2TensinsIBA
03/2018 - 01/2016
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018 - 01/2017
2Janus Kinase InhibitorsIBA
01/2017 - 01/2017
2Calbindin 2IBA
07/2016 - 08/2014
2Phosphotransferases (Kinase)IBA
10/2015 - 02/2009
2Progesterone Receptors (Progesterone Receptor)IBA
07/2015 - 01/2005
2Estrogen ReceptorsIBA
07/2015 - 01/2005
2AsbestosIBA
03/2015 - 08/2014
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2015 - 05/2005
2DNA (Deoxyribonucleic Acid)IBA
05/2008 - 05/2005
2raltitrexed (D 1694)IBA
11/2006 - 11/2005
2AnthracyclinesIBA
07/2006 - 08/2005
2Epirubicin (Ellence)FDA LinkGeneric
07/2006 - 08/2005
2Fluorouracil (Carac)FDA LinkGeneric
11/2005 - 08/2005
2Cisplatin (Platino)FDA LinkGeneric
12/2003 - 01/2003
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
12/2023
1SphingomyelinsIBA
12/2023
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2023
1Peptide Hydrolases (Proteases)FDA Link
01/2023
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2023
1SteroidsIBA
01/2023
1Apoptosis Regulatory ProteinsIBA
02/2022
1CTLA-4 AntigenIBA
02/2022
1tazemetostatIBA
01/2022
1atezolizumabIBA
10/2021
1Programmed Cell Death 1 ReceptorIBA
10/2021
1NivolumabIBA
10/2021
1Advanced Glycation End ProductsIBA
06/2021
1Immune Checkpoint ProteinsIBA
06/2021

Therapy/Procedure

18Therapeutics
01/2023 - 08/2005
9Drug Therapy (Chemotherapy)
01/2021 - 01/2003
4Immunotherapy
05/2023 - 11/2018
3Adjuvant Chemotherapy
07/2017 - 08/2005
3Radiotherapy
08/2010 - 11/2005
2Precision Medicine
10/2021 - 04/2018
2Operative Surgical Procedures
12/2015 - 07/2007
2Thyroidectomy
11/2009 - 01/2007
1Lasers (Laser)
10/2021